Soleno Therapeutics Inc.

NASDAQ: SLNO · Real-Time Price · USD
71.63
-5.73 (-7.41%)
At close: Aug 15, 2025, 3:59 PM
72.00
0.52%
After-hours: Aug 15, 2025, 07:57 PM EDT

Soleno Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-181.08M -198.22M -175.85M -131.16M -65.41M -52.03M -38.99M -33.18M -28.45M -26.7M -24.07M -21.41M -23.42M -27.68M -30.91M -30.93M -31.34M -27.73M
Depreciation & Amortization
2.01M 2M 1.99M 1.97M 1.96M 1.96M 1.96M 1.96M 1.96M 1.96M 1.96M 1.97M 1.97M 1.97M 1.96M 1.96M 1.96M 1.95M
Stock-Based Compensation
110.73M 108.19M 99.96M 72.11M 17.71M 11.76M 5.95M 4.67M 3.15M 2.52M 2.53M 2.32M 2.54M 2.83M 3.28M 3.25M 2.72M 2.2M
Other Working Capital
-3.41M -3.16M -3.06M -1.22M -362K -483K 1.56M -21K -279K -254K 721K -514K -389K -639K -913K -255K -175K 701K
Other Non-Cash Items
-16.49M 14.65M 17.21M 21.61M 20.21M 7.58M 5.42M 1.36M 477K 757K -452K -3.19M -2.77M -348K -443K 3.03M 3.26M 3.06M
Deferred Income Tax
n/a n/a n/a -2.85M -2.2M -2.2M -2.2M 652K -1K n/a n/a -139K -251K -307K -508K -5.47M -4.67M -8.43M
Change in Working Capital
-1.64M -5.69M 2.61M 1.91M -102K 4.75M 2.93M 770K 771K 316K -756K -2.05M -1.32M -3.1M -1.15M 393K -453K 1.89M
Operating Cash Flow
-84.28M -89.32M -69.1M -51.42M -42.83M -30.74M -24.94M -23.77M -22.09M -21.15M -20.78M -22.5M -23.25M -26.64M -27.77M -27.77M -28.53M -27.05M
Capital Expenditures
-213K -212K -218K -210K -19K -11K n/a -6K -13K -20K -20K -27K -25K -18K -22K -13K -11K -11K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-200.08M -286.59M -356.46M -308.92M -261.15M -115.23M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
225.8M 199.3M 131M 77M 25M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a -120.91M -236.15M -236.15M -236.15M -115.23M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
25.5M -87.5M -225.68M -232.13M -236.16M -115.24M n/a -6K -13K -20K -20K -27K -25K -18K -22K -13K -11K -11K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -5K -5K -3K -8K -7K -12K -18K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -120K -120K -120K -120K
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
78.88M 215.94M 213.66M 162.23M 195.85M 43.1M 42.16M 21.39M -15.14M -15.14M -15.15M -16K -16K -16K -120K -120K -120K 53.85M
Financial Cash Flow
78.25M 215.31M 213.03M 279.52M 316.65M 180.96M 180.02M 42.71M 3.65M -13.69M 342K 14.09M 13.74M 14.03M -128K -165K -360K 53.6M
Net Cash Flow
19.47M 38.48M -81.75M -4.02M 37.66M 34.97M 155.08M 32.69M -4.7M -21.1M -6.7M -8.43M -9.53M -12.63M -27.92M -27.95M -28.9M 26.54M
Free Cash Flow
-84.49M -89.53M -69.31M -51.63M -42.84M -30.75M -24.94M -23.77M -22.11M -21.17M -20.8M -22.53M -23.28M -26.66M -27.79M -27.79M -28.54M -27.06M